Cardiff Oncology, Inc. (CRDF)

[briphelps]

Welch is a man who brings products to there peak. He did that at the other co and pps went up big. It wasn't B Welch fault the pps fell, the product failed, not him.
He has experience in marketing with comm products, he has many connections! We don't need Matt Posard, and even if Matt were in the loop? Trov is still a winner. This will head up so much further once doctors and insurance co's accept this as the only way to monitor cancers. Cost effective and accurate.
Asco is coming up shorting in June. Expect a big news event.
Yes shorts are getting backed in a tight corner, and they think they have it under control. But just one news leak or a write up in Medical Journal, this will finally get going.
Many publications to come. Drink some tea and watch the show.